Tag Archives: Allergan

Breast Implants Recall: Allergan Textured Products In Europe Removed From Market In December 2018

Regulatory Action In France Due To Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Cases   (Posted by Tom Lamb at DrugInjuryWatch.com)   There have been more than 600 cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) reported worldwide, which … Continue reading

Posted in Products Liability | Tagged , , , , , , , , , , | Leave a comment

St. Regis Mohawk Tribe (and Allergan) File Motion to Preclude PTAB Decision on Sovereign Immunity

By Kevin E. Noonan — The St. Regis Mohawk Tribe and Allergan filed a joint motion late last week before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board (PTAB), arguing that its Notice of Appeal divested the … Continue reading

Posted in Intellectual Property | Tagged , , , , , , , , , , | Leave a comment

St. Regis Mohawk Tribe and Allergan Appeal Denial of Motion to Dismiss on Sovereign Immunity Grounds

By Kevin E. Noonan — Clearly wishing to maintain the momentum and initiative in its inter partes review proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office, the St. Regis Mohawk Tribe and Allergan … Continue reading

Posted in Intellectual Property | Tagged , , , , , , , , , , | Leave a comment